2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$56.74+$0.84 (+1.50%)
Price as of Jun 23, 2026 1:44 PM EDT- $10.8BMarket Cap
- 3.37%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$56.74+$0.84 (+1.50%)
BMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.90 | ||
Change | +$1.21 (+2.21%) | ||
Open | $55.51 | ||
High | $56.31 | ||
Low | $54.96 | ||
Previous Close | $54.69 | ||
Volume | 3,014,592 | ||
30-Day Average Volume | 2,333,468 | ||
1-Week Change | 0.45% | ||
1-Month Change | 3.35% | ||
1-Year Change | 3.37% | ||
3-Year Change | -41.53% | ||
5-Year Change | -31.11% | ||
Fundamentals | |||
Shares Outstanding | 193.3M | ||
Total Assets | $8.6B | ||
Market Cap | $10.8B | ||
Enterprise Value | $10.0B | ||
Period: QTR TTM FY | |||
Revenue | $760.1M | ||
Net Income | $105.5M | ||
Free Cash Flow | $199.7M | ||
EBIT | $150.8M | ||
EBITDA | $167.2M | ||
Net Working Capital | $3.8B | ||
EPS | $0.54 | ||
Enterprise Value/EBITDA | 60 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 2 | ||
P/E | 104 | ||
PEG | 0 | ||
Price/Free Cash Flow | 54 | ||
Price/Operating Cash Flow | 49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue